Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-005754
Filing Date
2023-01-31
Accepted
2023-01-31 17:21:37
Documents
1
Period of Report
2023-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7594
  Complete submission text file 0001209191-23-005754.txt   9163
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 310 UTAH AVE, STE. 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE, STE. 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
Shabbir Anik (Reporting) CIK: 0001751728 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 23573483